These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 7720083

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Class II (I-Ad) restricted T-cell recognition of the V3 loop region of HIV-1 gp120.
    Warren AP, Thomas DB.
    AIDS Res Hum Retroviruses; 1992 May; 8(5):559-64. PubMed ID: 1381202
    [Abstract] [Full Text] [Related]

  • 43. Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles.
    Harris SJ, Gearing AJ, Layton GT, Adams SE, Kingsman AJ.
    Immunology; 1992 Nov; 77(3):315-21. PubMed ID: 1362183
    [Abstract] [Full Text] [Related]

  • 44. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine.
    Fuller DH, Haynes JR.
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1433-41. PubMed ID: 7888198
    [Abstract] [Full Text] [Related]

  • 45. Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine.
    Takeda S, Shiosaki K, Kaneda Y, Nakasatomi T, Yoshizaki H, Someya K, Konno Y, Eda Y, Kino Y, Yamamoto N, Honda M.
    Clin Immunol; 2004 Jul; 112(1):92-105. PubMed ID: 15207786
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Effect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates.
    Kiszka I, Kmieciak D, Gzyl J, Naito T, Bolesta E, Sieron A, Singh SP, Srinivasan A, Trinchieri G, Kaneko Y, Kozbor D.
    J Virol; 2002 May; 76(9):4222-32. PubMed ID: 11932387
    [Abstract] [Full Text] [Related]

  • 48. CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity.
    Bijker MS, van den Eeden SJ, Franken KL, Melief CJ, Offringa R, van der Burg SH.
    J Immunol; 2007 Oct 15; 179(8):5033-40. PubMed ID: 17911588
    [Abstract] [Full Text] [Related]

  • 49. Strong synergistic effects of multicomponent vaccine for human immunodeficiency virus infection.
    Okuda K, Kaneko T, Yamakawa T, Tanaka S, Hamajima K, Shigematsu T, Yamamato A, Kawamoto S.
    J Clin Lab Immunol; 1993 Oct 15; 40(3):97-113. PubMed ID: 7877154
    [Abstract] [Full Text] [Related]

  • 50. Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1.
    O'Hagan DT, Ugozzoli M, Barackman J, Singh M, Kazzaz J, Higgins K, Vancott TC, Ott G.
    Vaccine; 2000 Mar 06; 18(17):1793-801. PubMed ID: 10699327
    [Abstract] [Full Text] [Related]

  • 51. Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector.
    Carbonetti NH, Tuskan RG, Lewis GK.
    AIDS Res Hum Retroviruses; 2001 Jun 10; 17(9):819-27. PubMed ID: 11429123
    [Abstract] [Full Text] [Related]

  • 52. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein.
    Bergmann C, Stohlmann SA, McMillan M.
    Eur J Immunol; 1993 Nov 10; 23(11):2777-81. PubMed ID: 7693478
    [Abstract] [Full Text] [Related]

  • 53. A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.
    Estaquier J, Boutillon C, Georges B, Ameisen JC, Tartar A, Auriault C.
    J Pept Sci; 1996 Nov 10; 2(3):165-75. PubMed ID: 9231325
    [Abstract] [Full Text] [Related]

  • 54. Effect of MTP-PE liposomes and interleukin-7 on induction of antibody and cell-mediated immune responses to a recombinant HIV-envelope protein.
    Bui T, Dykers T, Hu SL, Faltynek CR, Ho RJ.
    J Acquir Immune Defic Syndr (1988); 1994 Aug 10; 7(8):799-806. PubMed ID: 8021814
    [Abstract] [Full Text] [Related]

  • 55. Pimelautide or trimexautide as built-in adjuvants associated with an HIV-1-derived peptide: synthesis and in vivo induction of antibody and virus-specific cytotoxic T-lymphocyte-mediated response.
    Déprez B, Gras-Masse H, Martinon F, Gomard E, Lévy JP, Tartar A.
    J Med Chem; 1995 Feb 03; 38(3):459-65. PubMed ID: 7853339
    [Abstract] [Full Text] [Related]

  • 56. A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers.
    Evans TG, Keefer MC, Weinhold KJ, Wolff M, Montefiori D, Gorse GJ, Graham BS, McElrath MJ, Clements-Mann ML, Mulligan MJ, Fast P, Walker MC, Excler JL, Duliege AM, Tartaglia J.
    J Infect Dis; 1999 Aug 03; 180(2):290-8. PubMed ID: 10395842
    [Abstract] [Full Text] [Related]

  • 57. Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies.
    Kim M, Qiao ZS, Montefiori DC, Haynes BF, Reinherz EL, Liao HX.
    AIDS Res Hum Retroviruses; 2005 Jan 03; 21(1):58-67. PubMed ID: 15665645
    [Abstract] [Full Text] [Related]

  • 58. Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein.
    Zaghouani H, Anderson SA, Sperber KE, Daian C, Kennedy RC, Mayer L, Bona CA.
    Proc Natl Acad Sci U S A; 1995 Jan 17; 92(2):631-5. PubMed ID: 7831341
    [Abstract] [Full Text] [Related]

  • 59. Induction of HIV-specific CTL and antibody responses in mice using retroviral vector-transduced cells.
    Warner JF, Anderson CG, Laube L, Jolly DJ, Townsend K, Chada S, St Louis D.
    AIDS Res Hum Retroviruses; 1991 Aug 17; 7(8):645-55. PubMed ID: 1931234
    [Abstract] [Full Text] [Related]

  • 60. Comparison of nucleic acid and protein immunization for induction of antibodies specific for HIV-1 gp120.
    Peet NM, McKeating JA, Ramos B, Klonisch T, De Souza JB, Delves PJ, Lund T.
    Clin Exp Immunol; 1997 Aug 17; 109(2):226-32. PubMed ID: 9276516
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.